Mozifor 24 mg/1.2 mL Injection Mozifor 24 mg/1.2 mL Injection contains plerixafor, a hematopoietic stem cell mobilizer used to increase the number of blood-forming stem cells in the bloodstream. It is used together with granulocyte-colony stimulating factor (G-CSF) to help collect stem cells for subsequent autologous stem cell transplantation in eligible patients with conditions such as multiple myeloma and non-Hodgkin lymphoma.

Effects & Benefits Helps mobilize hematopoietic stem cells from the bone marrow into the bloodstream. Increases the availability of stem cells for collection by apheresis. Supports preparation for autologous stem cell transplantation. Used in eligible patients with multiple myeloma. Used in eligible patients with non-Hodgkin lymphoma. Works in combination with G-CSF as part of a stem-cell collection regimen.